Kalvin Yu

16.1k total citations
72 papers, 965 citations indexed

About

Kalvin Yu is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, Kalvin Yu has authored 72 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 29 papers in Applied Microbiology and Biotechnology and 20 papers in Infectious Diseases. Recurrent topics in Kalvin Yu's work include Antibiotic Use and Resistance (29 papers), Antibiotic Resistance in Bacteria (20 papers) and Urinary Tract Infections Management (20 papers). Kalvin Yu is often cited by papers focused on Antibiotic Use and Resistance (29 papers), Antibiotic Resistance in Bacteria (20 papers) and Urinary Tract Infections Management (20 papers). Kalvin Yu collaborates with scholars based in United States, United Kingdom and Canada. Kalvin Yu's co-authors include Vikas Gupta, Gang Ye, Laura Puzniak, Lyn Finelli, Karri A. Bauer, Sara Y. Tartof, Günter Rieg, Kenneth Lawrence, Melanie Olesky and John Murray and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Kalvin Yu

65 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kalvin Yu United States 18 428 338 253 222 151 72 965
Aurora Pop‐Vicas United States 16 478 1.1× 195 0.6× 257 1.0× 279 1.3× 114 0.8× 42 982
Lindsay A Petty United States 16 434 1.0× 378 1.1× 382 1.5× 123 0.6× 179 1.2× 57 1.1k
Brar Piening Germany 17 236 0.6× 156 0.5× 258 1.0× 243 1.1× 119 0.8× 39 1.1k
Kathleen Chiotos United States 17 356 0.8× 159 0.5× 296 1.2× 220 1.0× 106 0.7× 65 1.1k
Anne Savey France 20 464 1.1× 320 0.9× 293 1.2× 304 1.4× 128 0.8× 40 1.3k
Katrien Latour Belgium 11 367 0.9× 301 0.9× 280 1.1× 170 0.8× 88 0.6× 30 878
Aline Wolfensberger Switzerland 15 266 0.6× 165 0.5× 280 1.1× 175 0.8× 62 0.4× 55 892
Bongyoung Kim South Korea 18 425 1.0× 302 0.9× 172 0.7× 190 0.9× 102 0.7× 102 1.1k
Sarah K. Parker United States 20 518 1.2× 444 1.3× 429 1.7× 105 0.5× 401 2.7× 84 1.6k
Sorabh Dhar United States 18 239 0.6× 214 0.6× 222 0.9× 444 2.0× 134 0.9× 55 931

Countries citing papers authored by Kalvin Yu

Since Specialization
Citations

This map shows the geographic impact of Kalvin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalvin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalvin Yu more than expected).

Fields of papers citing papers by Kalvin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalvin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalvin Yu. The network helps show where Kalvin Yu may publish in the future.

Co-authorship network of co-authors of Kalvin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Kalvin Yu. A scholar is included among the top collaborators of Kalvin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalvin Yu. Kalvin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mohanty, Salini, Nicole Cossrow, Kalvin Yu, et al.. (2024). Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from 2015 to 2020. International Journal of Infectious Diseases. 143. 107023–107023. 7 indexed citations
4.
Yu, Kalvin, et al.. (2024). Clinical characteristics associated with hospital-onset bacteremia and fungemia among cancer and transplant patients. Infection Control and Hospital Epidemiology. 45(12). 1391–1398. 1 indexed citations
5.
Mohanty, Salini, Nicole Cossrow, Meghan White, et al.. (2024). Burden of invasive pneumococcal disease, non-invasive all-cause pneumonia, and acute otitis media in hospitalized US children: a retrospective multi-center study from 2015 to 2020. BMC Health Services Research. 24(1). 1574–1574. 1 indexed citations
6.
Jinks, Timothy, Sumithra Subramaniam, Matteo Bassetti, et al.. (2024). Opportunities to Enhance Diagnostic Testing and Antimicrobial Stewardship: A Qualitative Multinational Survey of Healthcare Professionals. Infectious Diseases and Therapy. 13(7). 1621–1637. 7 indexed citations
7.
Yu, Kalvin, Gang Ye, Jonathan R. Edwards, et al.. (2023). Treated, hospital-onset Clostridiodes difficile infection: An evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals. Infection Control and Hospital Epidemiology. 45(1). 48–56. 2 indexed citations
8.
Mohanty, Salini, et al.. (2023). Trends inStreptococcus pneumoniaeAntimicrobial Resistance in US Children: A Multicenter Evaluation. Open Forum Infectious Diseases. 10(3). ofad098–ofad098. 19 indexed citations
9.
Bauer, Karri A., Laura Puzniak, Kalvin Yu, et al.. (2023). Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021). BMC Infectious Diseases. 23(1). 490–490. 4 indexed citations
10.
Yu, Kalvin, et al.. (2023). Characteristics, costs, and outcomes associated with central-line–associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals. Infection Control and Hospital Epidemiology. 44(12). 1920–1926. 22 indexed citations
11.
Puzniak, Laura, et al.. (2023). A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves. BMC Infectious Diseases. 23(1). 117–117. 1 indexed citations
13.
Bauer, Karri A., Laura Puzniak, Kalvin Yu, et al.. (2022). Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation. BMC Infectious Diseases. 22(1). 841–841. 13 indexed citations
14.
Aronin, Steven I., et al.. (2022). Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 – 2020. Diagnostic Microbiology and Infectious Disease. 103(4). 115717–115717. 10 indexed citations
16.
Puzniak, Laura, Vikas Gupta, Kalvin Yu, Gang Ye, & Kevin Outterson. (2021). The impact of infections on reimbursement in 92 US hospitals, 2015-2018. American Journal of Infection Control. 49(10). 1275–1280. 4 indexed citations
17.
Puzniak, Laura, Lyn Finelli, Kalvin Yu, et al.. (2021). A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19. BMC Infectious Diseases. 21(1). 227–227. 23 indexed citations
18.
Yu, Kalvin & Eric S. Daar. (2000). Dual protease inhibitor therapy in the management of the HIV-1. Expert Opinion on Pharmacotherapy. 1(7). 1331–1342. 8 indexed citations
19.
Yu, Kalvin & Eric S. Daar. (2000). Primary HIV infection. Postgraduate Medicine. 107(4). 114–122. 4 indexed citations
20.
Chapman, Julia, Yona Tadir, Bruce J. Tromberg, et al.. (1993). Effect of administration route and estrogen manipulation on endometrial uptake of Photofrin porfimer sodium. American Journal of Obstetrics and Gynecology. 168(2). 685–692. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026